{"ticker": {"uuid": "6ac17112-224a-4034-ba52-6d46ce64f660", "symbol": "AZN", "name": "AstraZeneca PLC", "exchange": "BUE", "country": "AR", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-20T02:07:00+00:00", "published_display": "20 Jun 2026 02:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T16:33:51+00:00", "published_display": "19 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T13:09:58+00:00", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZN News | ASTRAZENECA PLC (NYSE:AZN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzTy1SNW8tSjBhVk55dU9wRjNZN051UXhHOWRrSnBPcE8wajNYQ1JQV2FFRE1WbnRsZVF0UnNBcjRCYmgxM1l4QU4wS2U5X0ZjeG5ER2dwZW0yZw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:04:00+00:00", "published_display": "19 Jun 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T22:15:04+00:00", "published_display": "18 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOcHZERjlmdHNzTWs4azdJV2ttdkMwc240OGF1NGExRW5mUldJT3VkaFgyOFJjVmEyeTB1TjAwV0lUeHdPc045alVtSnBkbk1KcFZNTmpyMEszbnB2NFFwNnpyeGxTTnlVbkc5M21xTlZldjVLMl9lV09WbEtNYUlmR193RHpXWXNTQmpVYzV5TUp4clJEeF9RNUFFTzV0enJCLTRWbDdhYVp3WDdF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T20:05:06+00:00", "published_display": "16 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQV1NNQkU0OEpQdUhpb19pNm1OZ0ljd0tiaVpVWkFac3MyM09YRlZPT29Fd2dKR1FXU0o0OV9pdVFPUUxkWDJ6QjZlY1c3bGdPaTdHVWRYcFBxLW84RVJrb0FJT1hiVG94QzBxRVZVNE0tbjg1OVQybFczbHVqbnNCYWN0RmRhYWdZYXNwenByS1pLWnNCazRYWjhKUkhKQXRjTExwOURLWk0?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-06-16T13:58:20+00:00", "published_display": "16 Jun 2026 13:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNWXJhbzJEU0Y3UmxWcGJaS3ZQdExIVmZiN2dTS0NIVGpURklUOFNUcDhWNTd6Yi1TYXM5YWRKQzg2UDRoV1FpSzBGWXJZeGROR1N5bXd4UF9ZU0VDVDdJUU9OU21HRkdrNm5OUnIxWGRpQkNJb1l2QTNIdDdmWWhVZkxxd1AwcnFlZlhUWEIyWEs3X0RuYlR3bUE2bG44eDV0Mkd5ak45MWNhSlU?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi\u2011Year Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOa3VRV043YkI2dmVxQ1g2MDkyazR4b29RcmU3bHYzVDcwV2Y2SXBIVFhoZ1RERjJDUXFyQjJsTlAwemI5TFVDbHpWVXdMdGpYLWdjQndoV09aRExjang0TW9jaE53dmRCQzMwM29Ib2JGTTRhU3pjd2U2M0VsOWZZQnQwT3hNRlpVTXV0Z2pKWHBXUXhxMXNHSnRPWFBIUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPaVJIMWY2T2Vfb3JHUnRJdmRTczJyWVV4ZzFBRC1UclF1c1hDZno5Z1hqaF84cmsybmR3Q1BQdVRGekxVREY0aXE2djY5NHF6YzNrOFdRbUVwRjdTQ3hwMVY5ZHY4UzhLSkNzd3VZeEl6ai04b3lsUHAwRkhKTG9LVzNRbC04akJJdWVpTnNueDFBM0F3TTFmdHF3Mm5pcXRYam44aFh3anhQeEFV?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Selling pressure pushes AstraZeneca stock lower in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYlNhMkJaMWdta2hSTXBxUlZNeGU5QjlGS2N2bmdhNUFTOXpyMTVrTmcwLXBXVkpubjR6NWtvR3JLZkRJSWdpN19mZElUUnFWUlk0XzNPSXlMMm5JMWNPMGE5c3ZQX2NNYTNESjVFTTBpS1pHSExQMUZfZUtVQkZJZFR5bnlzalJ4czRYeGhyZEdjaGlrcE5weGpGaw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is AstraZeneca stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNOUhLMWsyNzRWOWppU1F0WlYyZTlDUkhhSkdfU3VjUkN0TEJzX0NOTzdKa3NJT1FPWm5uQlBMb1c0cERoR2NydnBKcDVRc2lScHJSQXNHYVQ4eVMzYVlNVk9fSmltakZRRmotYUFyMVRQSUpGNWtMbnRVVlk5ZEU2LTZ6REdHeVVnbXdSV3hyTDBCakVxVWxNdUFCYw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC Stock (AZN) Closed Down by 3.17% on Jun 1: Facts Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVFg1VE5ObzZBRjF6RGoyVlBRTEozbE91OUI1NXlEWHg0eWR1X19rWjFqSUlnVERWTGVTOFR6YklPclJ5NEpzRVphQUZpdUpHS2libVRDYzEwN3FUZlFrd2JqeWgzMC1ac2hHNXJ5YXM2b1ZOZXJuMUhfakJGdXhYSTd2RWhTZjZjYnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Down 3.2% but Still Overvalued -- GF Score: 84/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOdXp4alF1dXp4TXZULWFac2dCSi1MQm5IQUgwLUpIYlEzWVBFSHlUajR6WWRrQThncU1pVUNvSEo0NXZoYXBmT3I1TDdyQzJQbk1ZV2Z6X3hHQm02RFZpYmVBQjAzbXYzVFMxSUpyNUVxeE4zSFlaZGlqUTNCc0Q4S2VMNGliTVZBc0lVZmFoWDlBZDhYdFU1d1V0ei1sZHp1RTdJakk4OEMtaFNkNjA5TzhEWmRKNVRHRGdnSQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GBX13,450 support underpins AstraZeneca stock near current levels", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNcE5uTzF4X2F2N0R0cTZrbnpRNWpCc2FSTjlBVVpvZS1Ib1JXXzhzSEtaMEJ0aW9WN1lXMl9RWVlDT0c2R0tSYmFnS3pNOWE0MXpsN0FfN29tdTJTY3JjaDlNTDZTMC1NNDZwZ19ZQUpUdTF5RU9Yd09QY1JUUjlsMHNhUXFYa21ZVzk2SzE2OGd2RHAwY0Z3ZncxTS1QdG5SYWlSQVNn?oc=5", "source_name": "Traders Union", "published_at": "2026-05-24T21:02:11+00:00", "published_display": "24 May 2026 21:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Flat trading for AstraZeneca stock as GBX13,902 resistance keeps gains in check", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWEJaTF81WUhMMHpMNFlkQkx1aW1rcGtqTVRFREhNa1ZVZ01SSVJQLU5TZE83bVpxS2NvQ1V1QW9hS25XTmNRRTFtVENxcXdFTXhXaW5rZXdFZHo1TTZpVEU5RDdqTmVMUk9jczRCLXlSYVcxUG4tWTVNNmFqTFFoRkhuNWVuYWRkUFh2bnBKaUNvZXo0WTNHUmRkaw?oc=5", "source_name": "Traders Union", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeHZ6UHg5WDVmaV9qaFNPaDNYeFlycnpOUGZwX1F3OFJtUnBGZkNfQ2RWY2Z6Ty1PeXNiUlNDSGZ3cEFwMGlKaHhySTUtdEI2cVhKVEc2YS1jV0NGMGQwZnBVLTg0cUNfa2hPS2pseDBoVERvcVQ0a1R3V2lFWjV0dU5FTFp1VzljYi11aWxYY25vNlRyb3RPbjBBQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOQnpjRDJxVHpwbFBzR0tkZmxtSlNaOE5IQnJTMTR2SGplM3JEVXNxM2FYb0M3ZThGSDdYaVc1bjlwTHEzR0xPcXo3MS0zc09MZkN3TUxwRU8ycEhHY28yQ2c5UUtJVm1jTHM5MWwtLU9USGFORzZ2ZEN2dmVEVzZ4UExKbm1EbVJSblRsb3huUXVaVWJaYXg1bGZJM0F2dU5TNVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNX1hhOU1xaVRCYVNQNHlvd1Q1VmhpdjFybG9nUlIzai1ObmVuY3FVbmVWYUFOTkxQeW5yaTlXdkpPandQRXhHUXRNZnc0U2ZXYjN2NjFNbHA4QnhuSUZNYjJDOTFkTkp1TGs5bmNTakk5d2xWbFZWSHhuRjR5aUluTy1ST3BYNDlmeTVUd0pvRFRHSjlOUDlkRGprWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca shares drop after US regulators vote against breast cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5GTlZBRU0xZk1EUDRuWUVlZ3ZVY0kxRFNuR3pQVEdDNkdtaGhPREtBOEFWdkxZSU54WlFZbjU3cmxncDQzWXY5dVh2Tmo4eXNvdl9OaUh1YWtDTm1rVUUxTk9KOTliUTQ?oc=5", "source_name": "Reuters", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock falls after FDA panel votes against new cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYWQ4cWdTbU1Bekl1LVhWZjMtSjZFY2N3OGk1YlRzaXZiUkI1TVlJNm85Uk9iY0N2WmFwQkZiVW9aTEc0ZHhhUkRQalhkZ3ViNWx5TWhQcjNyMVpIWWJpNWlOb1Y2dUJRQTBQOXFsaVVNc3ljVC15ZnZzZVlFTWxUMnh0VGpXQdIBiwFBVV95cUxOb2JzdjJacWh4bE9nalhqcDJtNlVpVW1SZ1p2djJoSWt5NG8ycjhLejZOVmZPR1JmejJ3RjF4eUNIQ2c3STRZNFRuNTBFTktPOFpRMEREY2ZmT3I5aVZTSW9jOXVpOUtlWmczTmVYc3ZVM0hoakYwOHpSRldjRXBOMFdlRHBINVpxMC1F?oc=5", "source_name": "CNBC", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock slips as weak momentum limits further upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxONGN3d0pIZ0dZLUtYclV5cDRycG9JQXVYcV9ndnItdzZ3d0xEWUpfSlAySVBpbjE5eDl6eHF1d3ZfWXZTVVpZaldqSFdJRW5qX0Z1YjBnbVhoOVNISlk5ejhZbXFmX3dsSXFMQWlJWDY1U2JaZGtTbG9sYVBNeVk4YlhuZTMtTW9jZjNlY0V5VU4xb3pUVDZXUEdneDdJR0xkdUxULWxMVQ?oc=5", "source_name": "Traders Union", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock holds steady after Assetmark Inc. and Pursuit Wealth buy shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOVWdNN283MHlLQnhBeFJZOEFfT0pTNWZpYUgxWVUtM1QzVjR5THNnc2dKSmE1U3ZpQzBUNm5NejNoejJWT1VnZVZueUI4NnNWSGNtUTB1RlNucER0d2pJdm5sb2o0OFdJSmV1cWhoNnU0cDU3aThtRzZDcTM2bG84RnB1Z3pkOER4UlIyWTZNN0VxR2xTd1pRamdIcXhZZw?oc=5", "source_name": "Traders Union", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India - Over 30 MF schemes trimmed holdings in 8 stocks in March \u201926. Do you own any?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQZDMwNU42QkdWQjI3S2JLTUhSeVllQ1JsVW1JeVljVzV3cUVEUC13Qlhqd3JudmY5bGh2emhGcXBLQlRLbFFaMWI3U21iUFo0TXM1RGVXajlHMHE4RnhTNTRpNTZyUWtCYThEbW9QYkJkbjJqMTc4bGRiSkU1bW5majkzd3Fua29qaGRnMFppajVTcFFYZlo2TXRNbk5TNmc1TnlWdXJzbmlsbnlVWnFRUVNJUy13Rzh5SGxPT242VmlxMnByR2RzeXpWQ016Q2xtZFJiWDJKdTRjZmFDYTB6R25PT0c5bjVLblJ2SzJKZ2ZpM0lQTjZhNVd0czR5MTdS?oc=5", "source_name": "The Economic Times", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock holds steady after $191 million grant for Albemarle facility approved", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQQmVOWVNKQWVTRmc3Q1I0bkxBTXhSZGFCenVfdFZLWEEybzh1MnNSajd1R0MyYWxXNXdWWjZwTXBnV3Vjblc2THlKNklIY0hIMWs2MU1yN0E2bDFpZ29lVnNnaXRpOEFlLWw1aHlVWG9Na21ZMlhWVXE3cHYtcjZZZVJ2OHlPUU1paFZhRmo1SkI0eXhVOUthVy1nOW1IX0VGT0RyV3B3?oc=5", "source_name": "Traders Union", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNN2Nnc0hZMHM1V0o0QlpiTUZUTElrRDMxWFZ3SUttSk41Z01OWHFRV1dyY0ZTZGVrcEplSUJaNzdsWmQ0OTliY0MwZGxSNzg0MmVOZ3k4OU1OZXJJMEdhcWhZcmhRYl9TS2wwY3hZSkpIVERJdkJEWnhYZ2NTVU56V0x0UTV1Nm95YzE5NF84UGRtek1XNHF0VjE2dUJpUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strong clinical milestones drive AstraZeneca stock higher despite mixed momentum readings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOYmtFdFJaR0diZ0JEbTl4ekltcEdtZVpRdnZVVjNCWE5WWWRRWlNmQ1lMdDhYaldialBabGlqTkdKUldsZVg2dVUzOEloZDBEeHJFaXBFTDdPRXN3S1czWDduaTJkSUM3R3hvLWNOdkpaVGhfNS00Wm1lSE50cjJUa1RwQ3VPeHdJZHZqV3phUFlMSUhDWGFKeVJjSDBIbXRLTGc?oc=5", "source_name": "Traders Union", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdzZJRzllYkhyQmJkbnhFbGlwS2c0cmZFc3pzVTM3d2NfWVVheTAtbURpX2NDWUtReUpFT2tCTmU3NmhJcWExWjY0emZsY1dSQWJ0WnZJWjYzcktGZW9pLTViSnJRRUF4MVZBTFdZc0lhZlBiVmVhdWI5VXNHVlVtOFBra1Zmbmd1Sy1EWFhSMUpsRlVzRWZvUDk5aVNySmpIeW1BMnZucjltNnJGQm9QMXJNSnVfeFZHT09UU09wd0J4UDE4WnBiVU9n?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca\u2019s shares rise as it addresses China investigation", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOeUVWOWpBSUt2NjJVZW50b0RRY2pmVEgyd2p6dE13b2NRWmxnRDZuU2FmQmJDZjl4WUFkQkFmVDB3clZCNm1qRlA5RWxXS0RXWjV4MXczZ1Y0dHk1ZFc3YW1RY1FVMHEzSXdwVzI1LWRnU0NVVW54SWZGUjJtSm5Bd28tUTFGblV2djVRSXBUYmFKWEZXVFZBUlpmb2NSZHlKN3ZHUEVsUW1LaWZm?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-02-06T08:00:00+00:00", "published_display": "06 Feb 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argentina pushes AstraZeneca on COVID-19 vaccine supply amid holdups", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPbE53LTU5Y3FxRi1fSFduVi1fRnJDLUdWY3Z4bmZBTGVfdTNReXgzbng5NExyaHlMbTBYYXlYSElMc0dpWVlCdjJ0MndzUE1SOHF1bHM1NXg4YTNzRElyaTZJNktWUmtQVUdEQWY1R1ljQWxSMGZCTnNDNGZ1dDlfNVlqcF91X1dsOF90NkxuU0NpWnJLek15bElCUG1EUi14S0tPWEt5SktuanBRZ3lRaXRFbEdlUFg1MTZzR3hrX3NLbHN4QUFhWW5manBkY0JsVk1BRg?oc=5", "source_name": "Reuters", "published_at": "2021-04-28T07:00:00+00:00", "published_display": "28 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argentina, Mexico to produce AstraZeneca COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRkFfWDV2MnUtZE5iRElKOTI2TF9ZcGVYTDQxQ2RJRWtQQi15SVgyRzhMZmRJdGlBdzhZZ3Z1WUhndlpWa0dpSlU4aGg0eHI2RG5lTnE1SE90Y19nU2lFdlZhNkVRRlczclZvb0NveUdtSG5MOXRVdDRENmVCcHloN1dJYmFlWjh5eUgya0VZSi1NOHRQX1hybGxXRUtKRWo1WVFOZVBleV9NN1Axb3c?oc=5", "source_name": "Reuters", "published_at": "2020-08-12T07:00:00+00:00", "published_display": "12 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-20T02:07:00+00:00", "published_display": "20 Jun 2026 02:07", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T16:33:51+00:00", "published_display": "19 Jun 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T13:09:58+00:00", "published_display": "19 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZN News | ASTRAZENECA PLC (NYSE:AZN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFBzTy1SNW8tSjBhVk55dU9wRjNZN051UXhHOWRrSnBPcE8wajNYQ1JQV2FFRE1WbnRsZVF0UnNBcjRCYmgxM1l4QU4wS2U5X0ZjeG5ER2dwZW0yZw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:04:00+00:00", "published_display": "19 Jun 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T22:15:04+00:00", "published_display": "18 Jun 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (AZN) officer receives Ordinary Share award under incentive plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOcHZERjlmdHNzTWs4azdJV2ttdkMwc240OGF1NGExRW5mUldJT3VkaFgyOFJjVmEyeTB1TjAwV0lUeHdPc045alVtSnBkbk1KcFZNTmpyMEszbnB2NFFwNnpyeGxTTnlVbkc5M21xTlZldjVLMl9lV09WbEtNYUlmR193RHpXWXNTQmpVYzV5TUp4clJEeF9RNUFFTzV0enJCLTRWbDdhYVp3WDdF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T20:05:06+00:00", "published_display": "16 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQV1NNQkU0OEpQdUhpb19pNm1OZ0ljd0tiaVpVWkFac3MyM09YRlZPT29Fd2dKR1FXU0o0OV9pdVFPUUxkWDJ6QjZlY1c3bGdPaTdHVWRYcFBxLW84RVJrb0FJT1hiVG94QzBxRVZVNE0tbjg1OVQybFczbHVqbnNCYWN0RmRhYWdZYXNwenByS1pLWnNCazRYWjhKUkhKQXRjTExwOURLWk0?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-06-16T13:58:20+00:00", "published_display": "16 Jun 2026 13:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNWXJhbzJEU0Y3UmxWcGJaS3ZQdExIVmZiN2dTS0NIVGpURklUOFNUcDhWNTd6Yi1TYXM5YWRKQzg2UDRoV1FpSzBGWXJZeGROR1N5bXd4UF9ZU0VDVDdJUU9OU21HRkdrNm5OUnIxWGRpQkNJb1l2QTNIdDdmWWhVZkxxd1AwcnFlZlhUWEIyWEs3X0RuYlR3bUE2bG44eDV0Mkd5ak45MWNhSlU?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi\u2011Year Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOa3VRV043YkI2dmVxQ1g2MDkyazR4b29RcmU3bHYzVDcwV2Y2SXBIVFhoZ1RERjJDUXFyQjJsTlAwemI5TFVDbHpWVXdMdGpYLWdjQndoV09aRExjang0TW9jaE53dmRCQzMwM29Ib2JGTTRhU3pjd2U2M0VsOWZZQnQwT3hNRlpVTXV0Z2pKWHBXUXhxMXNHSnRPWFBIUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPaVJIMWY2T2Vfb3JHUnRJdmRTczJyWVV4ZzFBRC1UclF1c1hDZno5Z1hqaF84cmsybmR3Q1BQdVRGekxVREY0aXE2djY5NHF6YzNrOFdRbUVwRjdTQ3hwMVY5ZHY4UzhLSkNzd3VZeEl6ai04b3lsUHAwRkhKTG9LVzNRbC04akJJdWVpTnNueDFBM0F3TTFmdHF3Mm5pcXRYam44aFh3anhQeEFV?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Selling pressure pushes AstraZeneca stock lower in today's trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPYlNhMkJaMWdta2hSTXBxUlZNeGU5QjlGS2N2bmdhNUFTOXpyMTVrTmcwLXBXVkpubjR6NWtvR3JLZkRJSWdpN19mZElUUnFWUlk0XzNPSXlMMm5JMWNPMGE5c3ZQX2NNYTNESjVFTTBpS1pHSExQMUZfZUtVQkZJZFR5bnlzalJ4czRYeGhyZEdjaGlrcE5weGpGaw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is AstraZeneca stock down today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNOUhLMWsyNzRWOWppU1F0WlYyZTlDUkhhSkdfU3VjUkN0TEJzX0NOTzdKa3NJT1FPWm5uQlBMb1c0cERoR2NydnBKcDVRc2lScHJSQXNHYVQ4eVMzYVlNVk9fSmltakZRRmotYUFyMVRQSUpGNWtMbnRVVlk5ZEU2LTZ6REdHeVVnbXdSV3hyTDBCakVxVWxNdUFCYw?oc=5", "source_name": "Traders Union", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC Stock (AZN) Closed Down by 3.17% on Jun 1: Facts Behind the Movement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPVFg1VE5ObzZBRjF6RGoyVlBRTEozbE91OUI1NXlEWHg0eWR1X19rWjFqSUlnVERWTGVTOFR6YklPclJ5NEpzRVphQUZpdUpHS2libVRDYzEwN3FUZlFrd2JqeWgzMC1ac2hHNXJ5YXM2b1ZOZXJuMUhfakJGdXhYSTd2RWhTZjZjYnc?oc=5", "source_name": "TradingKey", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Down 3.2% but Still Overvalued -- GF Score: 84/100", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOdXp4alF1dXp4TXZULWFac2dCSi1MQm5IQUgwLUpIYlEzWVBFSHlUajR6WWRrQThncU1pVUNvSEo0NXZoYXBmT3I1TDdyQzJQbk1ZV2Z6X3hHQm02RFZpYmVBQjAzbXYzVFMxSUpyNUVxeE4zSFlaZGlqUTNCc0Q4S2VMNGliTVZBc0lVZmFoWDlBZDhYdFU1d1V0ei1sZHp1RTdJakk4OEMtaFNkNjA5TzhEWmRKNVRHRGdnSQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GBX13,450 support underpins AstraZeneca stock near current levels", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNcE5uTzF4X2F2N0R0cTZrbnpRNWpCc2FSTjlBVVpvZS1Ib1JXXzhzSEtaMEJ0aW9WN1lXMl9RWVlDT0c2R0tSYmFnS3pNOWE0MXpsN0FfN29tdTJTY3JjaDlNTDZTMC1NNDZwZ19ZQUpUdTF5RU9Yd09QY1JUUjlsMHNhUXFYa21ZVzk2SzE2OGd2RHAwY0Z3ZncxTS1QdG5SYWlSQVNn?oc=5", "source_name": "Traders Union", "published_at": "2026-05-24T21:02:11+00:00", "published_display": "24 May 2026 21:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Flat trading for AstraZeneca stock as GBX13,902 resistance keeps gains in check", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWEJaTF81WUhMMHpMNFlkQkx1aW1rcGtqTVRFREhNa1ZVZ01SSVJQLU5TZE83bVpxS2NvQ1V1QW9hS25XTmNRRTFtVENxcXdFTXhXaW5rZXdFZHo1TTZpVEU5RDdqTmVMUk9jczRCLXlSYVcxUG4tWTVNNmFqTFFoRkhuNWVuYWRkUFh2bnBKaUNvZXo0WTNHUmRkaw?oc=5", "source_name": "Traders Union", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Fresh Look At AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNeHZ6UHg5WDVmaV9qaFNPaDNYeFlycnpOUGZwX1F3OFJtUnBGZkNfQ2RWY2Z6Ty1PeXNiUlNDSGZ3cEFwMGlKaHhySTUtdEI2cVhKVEc2YS1jV0NGMGQwZnBVLTg0cUNfa2hPS2pseDBoVERvcVQ0a1R3V2lFWjV0dU5FTFp1VzljYi11aWxYY25vNlRyb3RPbjBBQQ?oc=5", "source_name": "Market source", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOQnpjRDJxVHpwbFBzR0tkZmxtSlNaOE5IQnJTMTR2SGplM3JEVXNxM2FYb0M3ZThGSDdYaVc1bjlwTHEzR0xPcXo3MS0zc09MZkN3TUxwRU8ycEhHY28yQ2c5UUtJVm1jTHM5MWwtLU9USGFORzZ2ZEN2dmVEVzZ4UExKbm1EbVJSblRsb3huUXVaVWJaYXg1bGZJM0F2dU5TNVE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNX1hhOU1xaVRCYVNQNHlvd1Q1VmhpdjFybG9nUlIzai1ObmVuY3FVbmVWYUFOTkxQeW5yaTlXdkpPandQRXhHUXRNZnc0U2ZXYjN2NjFNbHA4QnhuSUZNYjJDOTFkTkp1TGs5bmNTakk5d2xWbFZWSHhuRjR5aUluTy1ST3BYNDlmeTVUd0pvRFRHSjlOUDlkRGprWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca shares drop after US regulators vote against breast cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5GTlZBRU0xZk1EUDRuWUVlZ3ZVY0kxRFNuR3pQVEdDNkdtaGhPREtBOEFWdkxZSU54WlFZbjU3cmxncDQzWXY5dVh2Tmo4eXNvdl9OaUh1YWtDTm1rVUUxTk9KOTliUTQ?oc=5", "source_name": "Reuters", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock falls after FDA panel votes against new cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYWQ4cWdTbU1Bekl1LVhWZjMtSjZFY2N3OGk1YlRzaXZiUkI1TVlJNm85Uk9iY0N2WmFwQkZiVW9aTEc0ZHhhUkRQalhkZ3ViNWx5TWhQcjNyMVpIWWJpNWlOb1Y2dUJRQTBQOXFsaVVNc3ljVC15ZnZzZVlFTWxUMnh0VGpXQdIBiwFBVV95cUxOb2JzdjJacWh4bE9nalhqcDJtNlVpVW1SZ1p2djJoSWt5NG8ycjhLejZOVmZPR1JmejJ3RjF4eUNIQ2c3STRZNFRuNTBFTktPOFpRMEREY2ZmT3I5aVZTSW9jOXVpOUtlWmczTmVYc3ZVM0hoakYwOHpSRldjRXBOMFdlRHBINVpxMC1F?oc=5", "source_name": "CNBC", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock slips as weak momentum limits further upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxONGN3d0pIZ0dZLUtYclV5cDRycG9JQXVYcV9ndnItdzZ3d0xEWUpfSlAySVBpbjE5eDl6eHF1d3ZfWXZTVVpZaldqSFdJRW5qX0Z1YjBnbVhoOVNISlk5ejhZbXFmX3dsSXFMQWlJWDY1U2JaZGtTbG9sYVBNeVk4YlhuZTMtTW9jZjNlY0V5VU4xb3pUVDZXUEdneDdJR0xkdUxULWxMVQ?oc=5", "source_name": "Traders Union", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock holds steady after Assetmark Inc. and Pursuit Wealth buy shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOVWdNN283MHlLQnhBeFJZOEFfT0pTNWZpYUgxWVUtM1QzVjR5THNnc2dKSmE1U3ZpQzBUNm5NejNoejJWT1VnZVZueUI4NnNWSGNtUTB1RlNucER0d2pJdm5sb2o0OFdJSmV1cWhoNnU0cDU3aThtRzZDcTM2bG84RnB1Z3pkOER4UlIyWTZNN0VxR2xTd1pRamdIcXhZZw?oc=5", "source_name": "Traders Union", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India - Over 30 MF schemes trimmed holdings in 8 stocks in March \u201926. Do you own any?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQZDMwNU42QkdWQjI3S2JLTUhSeVllQ1JsVW1JeVljVzV3cUVEUC13Qlhqd3JudmY5bGh2emhGcXBLQlRLbFFaMWI3U21iUFo0TXM1RGVXajlHMHE4RnhTNTRpNTZyUWtCYThEbW9QYkJkbjJqMTc4bGRiSkU1bW5majkzd3Fua29qaGRnMFppajVTcFFYZlo2TXRNbk5TNmc1TnlWdXJzbmlsbnlVWnFRUVNJUy13Rzh5SGxPT242VmlxMnByR2RzeXpWQ016Q2xtZFJiWDJKdTRjZmFDYTB6R25PT0c5bjVLblJ2SzJKZ2ZpM0lQTjZhNVd0czR5MTdS?oc=5", "source_name": "The Economic Times", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock holds steady after $191 million grant for Albemarle facility approved", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQQmVOWVNKQWVTRmc3Q1I0bkxBTXhSZGFCenVfdFZLWEEybzh1MnNSajd1R0MyYWxXNXdWWjZwTXBnV3Vjblc2THlKNklIY0hIMWs2MU1yN0E2bDFpZ29lVnNnaXRpOEFlLWw1aHlVWG9Na21ZMlhWVXE3cHYtcjZZZVJ2OHlPUU1paFZhRmo1SkI0eXhVOUthVy1nOW1IX0VGT0RyV3B3?oc=5", "source_name": "Traders Union", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNN2Nnc0hZMHM1V0o0QlpiTUZUTElrRDMxWFZ3SUttSk41Z01OWHFRV1dyY0ZTZGVrcEplSUJaNzdsWmQ0OTliY0MwZGxSNzg0MmVOZ3k4OU1OZXJJMEdhcWhZcmhRYl9TS2wwY3hZSkpIVERJdkJEWnhYZ2NTVU56V0x0UTV1Nm95YzE5NF84UGRtek1XNHF0VjE2dUJpUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strong clinical milestones drive AstraZeneca stock higher despite mixed momentum readings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOYmtFdFJaR0diZ0JEbTl4ekltcEdtZVpRdnZVVjNCWE5WWWRRWlNmQ1lMdDhYaldialBabGlqTkdKUldsZVg2dVUzOEloZDBEeHJFaXBFTDdPRXN3S1czWDduaTJkSUM3R3hvLWNOdkpaVGhfNS00Wm1lSE50cjJUa1RwQ3VPeHdJZHZqV3phUFlMSUhDWGFKeVJjSDBIbXRLTGc?oc=5", "source_name": "Traders Union", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdzZJRzllYkhyQmJkbnhFbGlwS2c0cmZFc3pzVTM3d2NfWVVheTAtbURpX2NDWUtReUpFT2tCTmU3NmhJcWExWjY0emZsY1dSQWJ0WnZJWjYzcktGZW9pLTViSnJRRUF4MVZBTFdZc0lhZlBiVmVhdWI5VXNHVlVtOFBra1Zmbmd1Sy1EWFhSMUpsRlVzRWZvUDk5aVNySmpIeW1BMnZucjltNnJGQm9QMXJNSnVfeFZHT09UU09wd0J4UDE4WnBiVU9n?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca\u2019s shares rise as it addresses China investigation", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOeUVWOWpBSUt2NjJVZW50b0RRY2pmVEgyd2p6dE13b2NRWmxnRDZuU2FmQmJDZjl4WUFkQkFmVDB3clZCNm1qRlA5RWxXS0RXWjV4MXczZ1Y0dHk1ZFc3YW1RY1FVMHEzSXdwVzI1LWRnU0NVVW54SWZGUjJtSm5Bd28tUTFGblV2djVRSXBUYmFKWEZXVFZBUlpmb2NSZHlKN3ZHUEVsUW1LaWZm?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2025-02-06T08:00:00+00:00", "published_display": "06 Feb 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argentina pushes AstraZeneca on COVID-19 vaccine supply amid holdups", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPbE53LTU5Y3FxRi1fSFduVi1fRnJDLUdWY3Z4bmZBTGVfdTNReXgzbng5NExyaHlMbTBYYXlYSElMc0dpWVlCdjJ0MndzUE1SOHF1bHM1NXg4YTNzRElyaTZJNktWUmtQVUdEQWY1R1ljQWxSMGZCTnNDNGZ1dDlfNVlqcF91X1dsOF90NkxuU0NpWnJLek15bElCUG1EUi14S0tPWEt5SktuanBRZ3lRaXRFbEdlUFg1MTZzR3hrX3NLbHN4QUFhWW5manBkY0JsVk1BRg?oc=5", "source_name": "Reuters", "published_at": "2021-04-28T07:00:00+00:00", "published_display": "28 Apr 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argentina, Mexico to produce AstraZeneca COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRkFfWDV2MnUtZE5iRElKOTI2TF9ZcGVYTDQxQ2RJRWtQQi15SVgyRzhMZmRJdGlBdzhZZ3Z1WUhndlpWa0dpSlU4aGg0eHI2RG5lTnE1SE90Y19nU2lFdlZhNkVRRlczclZvb0NveUdtSG5MOXRVdDRENmVCcHloN1dJYmFlWjh5eUgya0VZSi1NOHRQX1hybGxXRUtKRWo1WVFOZVBleV9NN1Axb3c?oc=5", "source_name": "Reuters", "published_at": "2020-08-12T07:00:00+00:00", "published_display": "12 Aug 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 32, "sentiment_summary": {"positive": 6, "negative": 6, "neutral": 20, "score": 49, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 17.7, "count": 29}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.45, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.9, "count": 1}], "positive_events": 6, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 66925.0, "latest_week": "2026-06-12", "one_week_move": -4.6, "four_week_move": -0.6, "twelve_week_move": -0.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.94124, "market_dynamics_buy_signal": false, "relative_strength": -20.056966, "fair_value_gap": 78.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.2117, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.6% over one week, -0.6% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "Traders Union", "count": 8}, {"label": "Reuters", "count": 3}, {"label": "The Economic Times", "count": 2}, {"label": "simplywall.st", "count": 1}, {"label": "ChartMill", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Zacks Investment Research", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 32}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Regulatory and legal", "count": 2}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "32", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "7", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.6% over one week, -0.6% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate"}], "updated_at": "2026-06-22T20:22:19.008824+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}